Publications

• Mutated Chromatin Regulatory Factors As Tumor Drivers in Cancer
  Cancer Research. Jan, 2017  |   Pubmed ID: 28062403
• CXCR4 Increases In-vivo Glioma Perivascular Invasion, and Reduces Radiation Induced Apoptosis: A Genetic Knockdown Study
  Oncotarget. 12, 2016  |   Pubmed ID: 27863376
• Natural Killer Cells Require Monocytic Gr-1(+)/CD11b(+) Myeloid Cells to Eradicate Orthotopically Engrafted Glioma Cells
  Oncoimmunology. Jun, 2016  |   Pubmed ID: 27471637
• The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors
  Advances in Pharmacology (San Diego, Calif.). 2016  |   Pubmed ID: 27288077
• Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model
  Human Gene Therapy Methods. Jun, 2016  |   Pubmed ID: 27056322
• Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms
  Methods in Molecular Biology (Clifton, N.J.). 2016  |   Pubmed ID: 26611605
• Glioma Trials and Viral Tribulations: Can Anything Be Concluded from Non-controlled Trials?
  Journal of Neurology, Neurosurgery, and Psychiatry. Feb, 2015  |   Pubmed ID: 25280917
• Consensus Guidelines for the Detection of Immunogenic Cell Death
  Oncoimmunology. Oct, 2014  |   Pubmed ID: 25941621
• Cracking the Glioma-NK Inhibitory Code: Toward Successful Innate Immunotherapy
  Oncoimmunology. Nov, 2014  |   Pubmed ID: 25941594
• Blockade of MTOR Signaling Via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-cell Functions
  Molecular Cancer Therapeutics. Dec, 2014  |   Pubmed ID: 25256739
• Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-independent Vascularization, and Resistance to Antiangiogenic Therapy
  Neoplasia (New York, N.Y.). Jul, 2014  |   Pubmed ID: 25117977
• Marmosets As a Preclinical Model for Testing "off-label" Use of Doxycycline to Turn on Flt3L Expression from High-capacity Adenovirus Vectors
  Molecular Therapy. Methods & Clinical Development. Feb, 2014  |   Pubmed ID: 25068145
• Natural Killer Cells Eradicate Galectin-1-deficient Glioma in the Absence of Adaptive Immunity
  Cancer Research. Sep, 2014  |   Pubmed ID: 25038230
• Blocking Immunosuppressive Checkpoints for Glioma Therapy: the More the Merrier!
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2014  |   Pubmed ID: 24879798
• The Value of EGFRvIII As the Target for Glioma Vaccines
  American Society of Clinical Oncology Educational Book / ASCO. American Society of Clinical Oncology. Meeting. 2014  |   Pubmed ID: 24857059
• Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM
  PloS One. 2014  |   Pubmed ID: 24806510
• Adenoviral Vector-mediated Gene Therapy for Gliomas: Coming of Age
  Expert Opinion on Biological Therapy. Sep, 2014  |   Pubmed ID: 24773178
• Lentiviral-induced High-grade Gliomas in Rats: the Effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Jul, 2014  |   Pubmed ID: 24752661
• Preclinical Characterization of Signal Transducer and Activator of Transcription 3 Small Molecule Inhibitors for Primary and Metastatic Brain Cancer Therapy
  The Journal of Pharmacology and Experimental Therapeutics. Jun, 2014  |   Pubmed ID: 24696041
• Temozolomide Does Not Impair Gene Therapy-mediated Antitumor Immunity in Syngeneic Brain Tumor Models
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2014  |   Pubmed ID: 24501391
• Dendritic Cell-based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
  Neurologia Medico-chirurgica. 2013  |   Pubmed ID: 24140772
• Neuro-oncology: The Long and Winding Road--gene Therapy for Glioma
  Nature Reviews. Neurology. Nov, 2013  |   Pubmed ID: 24061435
• Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used "off-label" to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma
  Human Gene Therapy. Clinical Development. Sep, 2013  |   Pubmed ID: 24007469
• Progress in Gene Therapy for Neurological Disorders
  Nature Reviews. Neurology. May, 2013  |   Pubmed ID: 23609618
• Safety Profile, Efficacy, and Biodistribution of a Bicistronic High-capacity Adenovirus Vector Encoding a Combined Immunostimulation and Cytotoxic Gene Therapy As a Prelude to a Phase I Clinical Trial for Glioblastoma
  Toxicology and Applied Pharmacology. May, 2013  |   Pubmed ID: 23403069
• Gene Therapy-mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Oct, 2012  |   Pubmed ID: 22996231
• Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
  Neoplasia (New York, N.Y.). Aug, 2012  |   Pubmed ID: 22952428
• Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial
  Human Gene Therapy Methods. Aug, 2012  |   Pubmed ID: 22950971
• Gene Therapy for Brain Tumors: Basic Developments and Clinical Implementation
  Neuroscience Letters. Oct, 2012  |   Pubmed ID: 22906921
• Cytotoxic Immunological Synapses Do Not Restrict the Action of Interferon-γ to Antigenic Target Cells
  Proceedings of the National Academy of Sciences of the United States of America. May, 2012  |   Pubmed ID: 22547816
• Pushing the Limits of Glioma Resection Using Electrophysiologic Brain Mapping
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2012  |   Pubmed ID: 22529267
• Immune-mediated Loss of Transgene Expression from Virally Transduced Brain Cells is Irreversible, Mediated by IFNγ, Perforin, and TNFα, and Due to the Elimination of Transduced Cells
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Apr, 2012  |   Pubmed ID: 22233583
• B Cells Are Critical to T-cell-mediated Antitumor Immunity Induced by a Combined Immune-stimulatory/conditionally Cytotoxic Therapy for Glioblastoma
  Neoplasia (New York, N.Y.). Oct, 2011  |   Pubmed ID: 22028620
• Identification and Visualization of CD8+ T Cell Mediated IFN-γ Signaling in Target Cells During an Antiviral Immune Response in the Brain
  PloS One. 2011  |   Pubmed ID: 21897844
• Targeted Toxins for Glioblastoma Multiforme: Pre-clinical Studies and Clinical Implementation
  Anti-cancer Agents in Medicinal Chemistry. Oct, 2011  |   Pubmed ID: 21707497
• Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2011  |   Pubmed ID: 21632862
• Moving Forward Toward a Cure for Parkinson's: Neuropathology of the Nigrostriatal Pathway Determines the Location of Growth Factor Delivery
  Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2011  |   Pubmed ID: 21532611
• Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Oct, 2011  |   Pubmed ID: 21505426
• Gene Therapy and Targeted Toxins for Glioma
  Current Gene Therapy. Jun, 2011  |   Pubmed ID: 21453286
• AAV6-mediated Gene Silencing FALS Short
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2011  |   Pubmed ID: 21289637
• Gene Therapy and Virotherapy: Novel Therapeutic Approaches for Brain Tumors
  Discovery Medicine. Oct, 2010  |   Pubmed ID: 21034670
• Gene Therapy-mediated Delivery of Targeted Cytotoxins for Glioma Therapeutics
  Proceedings of the National Academy of Sciences of the United States of America. Nov, 2010  |   Pubmed ID: 21030678
• Cancer Vaccines in Glioma: How to Balance the Challenges of Small Trials, Efficiency, and Potential Adverse Events
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2010  |   Pubmed ID: 20921460
• Exogenous Fms-like Tyrosine Kinase 3 Ligand Overrides Brain Immune Privilege and Facilitates Recognition of a Neo-antigen Without Causing Autoimmune Neuropathology
  Proceedings of the National Academy of Sciences of the United States of America. Aug, 2010  |   Pubmed ID: 20660723
• Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial
  PloS One. 2010  |   Pubmed ID: 20552015
• A Novel Bicistronic High-capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-inducible Expression of Flt3L for Glioma Therapeutics
  Journal of Virology. Jun, 2010  |   Pubmed ID: 20375153
• Anti-tumor Immune Response Correlates with Neurological Symptoms in a Dog with Spontaneous Astrocytoma Treated by Gene and Vaccine Therapy
  Vaccine. Apr, 2010  |   Pubmed ID: 20197146
• Gene Transfer into Rat Brain Using Adenoviral Vectors
  Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [et Al.]. Jan, 2010  |   Pubmed ID: 20066657
• Risk in Clinical Research: Size Matters!
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2009  |   Pubmed ID: 19876046
• Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety
  Current Gene Therapy. Oct, 2009  |   Pubmed ID: 19860655
• Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why Do Most Phase III Clinical Trials Fail?
  Current Gene Therapy. Oct, 2009  |   Pubmed ID: 19860651
• Gene Therapy Continues to Make Progress: Clinical and Regulatory Perspectives
  Current Gene Therapy. Oct, 2009  |   Pubmed ID: 19860647
• Challenges in the Evaluation, Consent, Ethics and History of Early Clinical Trials - Implications of the Tuskegee 'trial' for Safer and More Ethical Clinical Trials
  Current Opinion in Molecular Therapeutics. Oct, 2009  |   Pubmed ID: 19806495
• Antiglioma Immunological Memory in Response to Conditional Cytotoxic/immune-stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2009  |   Pubmed ID: 19789315
• Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells
  The American Journal of Pathology. Aug, 2009  |   Pubmed ID: 19628762
• Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2009  |   Pubmed ID: 19570774
• HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
  PLoS Medicine. Jan, 2009  |   Pubmed ID: 19143470
• Crossing the Rubicon
  Nature Biotechnology. Jan, 2009  |   Pubmed ID: 19131996
• Gene Transfer into Neural Cells in Vitro Using Adenoviral Vectors
  Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [et Al.]. Oct, 2008  |   Pubmed ID: 18972378
• A Call for Physiopathological Ethics
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2008  |   Pubmed ID: 18956015
• Clinical Trials in Gene Therapy: Ethics of Informed Consent and the Future of Experimental Medicine
  Current Opinion in Molecular Therapeutics. Oct, 2008  |   Pubmed ID: 18830917
• T Cells' Immunological Synapses Induce Polarization of Brain Astrocytes in Vivo and in Vitro: a Novel Astrocyte Response Mechanism to Cellular Injury
  PloS One. 2008  |   Pubmed ID: 18714338
• CD20, CD3, and CD40 Ligand Microclusters Segregate Three-dimensionally in Vivo at B-cell-T-cell Immunological Synapses After Viral Immunity in Primate Brain
  Journal of Virology. Oct, 2008  |   Pubmed ID: 18684835
• With a Little Help from My F(X)riends!: the Basis of Ad5-mediated Transduction of the Liver Revealed
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2008  |   Pubmed ID: 18500239
• Regulated Expression of Adenoviral Vectors-based Gene Therapies: Therapeutic Expression of Toxins and Immune-modulators
  Methods in Molecular Biology (Clifton, N.J.). 2008  |   Pubmed ID: 18470649
• Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
  PloS One. 2008  |   Pubmed ID: 18431473
• Gene Delivery to the Nervous System
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Apr, 2008  |   Pubmed ID: 18362921
• Turning the Gene Tap Off; Implications of Regulating Gene Expression for Cancer Therapeutics
  Molecular Cancer Therapeutics. Mar, 2008  |   Pubmed ID: 18347132
• High-capacity Adenovirus Vector-mediated Anti-glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity
  Journal of Virology. May, 2008  |   Pubmed ID: 18287240
• Flt3L in Combination with HSV1-TK-mediated Gene Therapy Reverses Brain Tumor-induced Behavioral Deficits
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Apr, 2008  |   Pubmed ID: 18283279
• In Vivo Polarization of IFN-gamma at Kupfer and Non-Kupfer Immunological Synapses During the Clearance of Virally Infected Brain Cells
  Journal of Immunology (Baltimore, Md. : 1950). Feb, 2008  |   Pubmed ID: 18209028
• Immunization Against the Transgene but Not the TetON Switch Reduces Expression from Gutless Adenoviral Vectors in the Brain
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2008  |   Pubmed ID: 18180781
• Flt3L and TK Gene Therapy Eradicate Multifocal Glioma in a Syngeneic Glioblastoma Model
  Neuro-oncology. Feb, 2008  |   Pubmed ID: 18079358
• Immune Responses to Adenovirus and Adeno-associated Vectors Used for Gene Therapy of Brain Diseases: the Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune Interactions
  Current Gene Therapy. Oct, 2007  |   Pubmed ID: 17979681
• Immunology of Neurological Gene Therapy: How T Cells Modulate Viral Vector-mediated Therapeutic Transgene Expression Through Immunological Synapses
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Oct, 2007  |   Pubmed ID: 17920552
• One-year Expression from High-capacity Adenoviral Vectors in the Brains of Animals with Pre-existing Anti-adenoviral Immunity: Clinical Implications
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2007  |   Pubmed ID: 17895861
• Improved Distribution of Small Molecules and Viral Vectors in the Murine Brain Using a Hollow Fiber Catheter
  Journal of Neurosurgery. Sep, 2007  |   Pubmed ID: 17886557
• Intracranial Glioblastoma Models in Preclinical Neuro-oncology: Neuropathological Characterization and Tumor Progression
  Journal of Neuro-oncology. Nov, 2007  |   Pubmed ID: 17874037
• Efficacy of Nonviral Gene Transfer in the Canine Brain
  Journal of Neurosurgery. Jul, 2007  |   Pubmed ID: 17639883
• Optimization of Adenoviral Vector-mediated Transgene Expression in the Canine Brain in Vivo, and in Canine Glioma Cells in Vitro
  Neuro-oncology. Jul, 2007  |   Pubmed ID: 17522335
• Adenoviral-mediated Gene Transfer into the Canine Brain in Vivo
  Neurosurgery. Jan, 2007  |   Pubmed ID: 17228266
• Immunological Thresholds in Neurological Gene Therapy: Highly Efficient Elimination of Transduced Cells Might Be Related to the Specific Formation of Immunological Synapses Between T Cells and Virus-infected Brain Cells
  Neuron Glia Biology. Nov, 2006  |   Pubmed ID: 18084640
• Immune Regulation of Transgene Expression in the Brain: B Cells Regulate an Early Phase of Elimination of Transgene Expression from Adenoviral Vectors
  Viral Immunology. 2006  |   Pubmed ID: 16987068
• In Vivo Mature Immunological Synapses Forming SMACs Mediate Clearance of Virally Infected Astrocytes from the Brain
  The Journal of Experimental Medicine. Sep, 2006  |   Pubmed ID: 16923851
• Effective High-capacity Gutless Adenoviral Vectors Mediate Transgene Expression in Human Glioma Cells
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2006  |   Pubmed ID: 16798098
• Rapid Upregulation of Interferon-regulated and Chemokine MRNAs Upon Injection of 108 International Units, but Not Lower Doses, of Adenoviral Vectors into the Brain
  Journal of Virology. Jun, 2006  |   Pubmed ID: 16699048
• Fms-like Tyrosine Kinase 3 Ligand Recruits Plasmacytoid Dendritic Cells to the Brain
  Journal of Immunology (Baltimore, Md. : 1950). Mar, 2006  |   Pubmed ID: 16517725
• Regulatable Gutless Adenovirus Vectors Sustain Inducible Transgene Expression in the Brain in the Presence of an Immune Response Against Adenoviruses
  Journal of Virology. Jan, 2006  |   Pubmed ID: 16352528
• Gene Therapy and Targeted Toxins for Glioma
  Current Gene Therapy. Dec, 2005  |   Pubmed ID: 16457645
• Platelets Mediate Cytotoxic T Lymphocyte-induced Liver Damage
  Nature Medicine. Nov, 2005  |   Pubmed ID: 16258538
• Combining Cytotoxic and Immune-mediated Gene Therapy to Treat Brain Tumors
  Current Topics in Medicinal Chemistry. 2005  |   Pubmed ID: 16248789
• Combined Immunostimulation and Conditional Cytotoxic Gene Therapy Provide Long-term Survival in a Large Glioma Model
  Cancer Research. Aug, 2005  |   Pubmed ID: 16103070
• Mutagenesis-induced, Large Fitness Variations with an Invariant Arenavirus Consensus Genomic Nucleotide Sequence
  Journal of Virology. Aug, 2005  |   Pubmed ID: 16051837
• The Case for Immunosuppression in Clinical Gene Transfer
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Aug, 2005  |   Pubmed ID: 16002339
• Stability of Lentiviral Vector-mediated Transgene Expression in the Brain in the Presence of Systemic Antivector Immune Responses
  Human Gene Therapy. Jun, 2005  |   Pubmed ID: 15960605
• Inflammatory and Anti-glioma Effects of an Adenovirus Expressing Human Soluble Fms-like Tyrosine Kinase 3 Ligand (hsFlt3L): Treatment with HsFlt3L Inhibits Intracranial Glioma Progression
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2004  |   Pubmed ID: 15564139
• The Collaborative Cross, a Community Resource for the Genetic Analysis of Complex Traits
  Nature Genetics. Nov, 2004  |   Pubmed ID: 15514660
• Effects of Ectopic Decorin in Modulating Intracranial Glioma Progression in Vivo, in a Rat Syngeneic Model
  Cancer Gene Therapy. Nov, 2004  |   Pubmed ID: 15475879
• Input Virion Proteins: Cryptic Targets of Antivector Immune Responses in Preimmunized Subjects
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2004  |   Pubmed ID: 15222326
• Development of a Novel Helper-dependent Adenovirus-Epstein-Barr Virus Hybrid System for the Stable Transformation of Mammalian Cells
  Journal of Virology. Jun, 2004  |   Pubmed ID: 15163748
• Gene Therapy for Liver Transplantation Using Adenoviral Vectors: CD40-CD154 Blockade by Gene Transfer of CD40Ig Protects Rat Livers from Cold Ischemia and Reperfusion Injury
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jan, 2004  |   Pubmed ID: 14741776
• Adenovirus-mediated Gene Transfer of Transforming Growth Factor-beta3, but Not Transforming Growth Factor-beta1, Inhibits Constrictive Remodeling and Reduces Luminal Loss After Coronary Angioplasty
  Circulation. Dec, 2003  |   Pubmed ID: 14638551
• Nonneurotropic Adenovirus: a Vector for Gene Transfer to the Brain and Gene Therapy of Neurological Disorders
  International Review of Neurobiology. 2003  |   Pubmed ID: 12968530
• Adenovirus Expression of IL-1 and NF-kappaB Inhibitors Does Not Inhibit Acute Adenoviral-induced Brain Inflammation, but Delays Immune System-mediated Elimination of Transgene Expression
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2003  |   Pubmed ID: 12946313
• Use of Recombinant Adenovirus for Gene Transfer into the Rat Brain. Evaluation of Gene Transfer Efficiency, Toxicity, and Inflammatory and Immune Reactions
  Methods in Molecular Medicine. 2003  |   Pubmed ID: 12526161
• Adenovirus Vector-mediated Delivery of the Prodrug-converting Enzyme Carboxypeptidase G2 in a Secreted or GPI-anchored Form: High-level Expression of This Active Conditional Cytotoxic Enzyme at the Plasma Membrane
  Cancer Gene Therapy. Nov, 2002  |   Pubmed ID: 12386828
• Progress and Challenges in Viral Vector-mediated Gene Transfer to the Brain
  Current Opinion in Molecular Therapeutics. Aug, 2002  |   Pubmed ID: 12222874
• Dendritic Cells and Immune Responses in the Central Nervous System
  Trends in Immunology. Feb, 2002  |   Pubmed ID: 11956012
• Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins is Not Required to Elicit Brain Inflammation but is Necessary to Transduce Specific Neural Cell Types
  Journal of Virology. Apr, 2002  |   Pubmed ID: 11884569
• Prolonged Blockade of CD40-CD40 Ligand Interactions by Gene Transfer of CD40Ig Results in Long-term Heart Allograft Survival and Donor-specific Hyporesponsiveness, but Does Not Prevent Chronic Rejection
  Journal of Immunology (Baltimore, Md. : 1950). Feb, 2002  |   Pubmed ID: 11823487
• Immunology of Viral-vector-mediated Gene Transfer into the Brain: an Evolutionary and Developmental Perspective
  Trends in Immunology. Jan, 2002  |   Pubmed ID: 11801451